# Mind Medicine (MindMed) Inc. (MNMD)

Source: https://www.quantisnow.com/company/MNMD
Generated: 2026-11-10T02:55:43.412Z

- Ticker: MNMD
- Exchange: NASDAQ
- Sector: Health Care
- Industry:  Medicinal Chemicals and Botanical Products 
- Website: mindmed.co

## About

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

## Latest MNMD news and filings

- 2026-01-12 13:24 UTC [SEC Form 8-K] [Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-filed-sec-form-8-k-results-of-6345750)
- 2025-12-29 22:00 UTC [SEC Form 4] [Chief Legal Officer Sullivan Mark sold $148,244 worth of shares (11,276 units at $13.15), decreasing direct ownership by 4% to 282,576 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-legal-officer-sullivan-mark-sold-148244-worth-of-shares-6328856)
- 2025-12-29 22:00 UTC [SEC Form 4] [Chief Executive Officer Barrow Robert sold $339,072 worth of shares (25,791 units at $13.15), decreasing direct ownership by 3% to 778,477 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-barrow-robert-sold-339072-worth-of-shares-6328854)
- 2025-12-29 22:00 UTC [SEC Form 4] [Chief Medical Officer Karlin Daniel sold $73,623 worth of shares (5,600 units at $13.15), decreasing direct ownership by 1% to 425,025 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-karlin-daniel-sold-73623-worth-of-shares-6328853)
- 2025-12-29 21:15 UTC [SEC Form 144] [SEC Form 144 filed by Mind Medicine (MindMed) Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mind-medicine-mindmed-inc-6328590)
- 2025-12-18 12:01 UTC [Conference Announcement] [MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference](https://www.quantisnow.com/insight/mindmed-to-present-at-the-44th-annual-jp-morgan-healthcare-6321188)
- 2025-12-15 21:01 UTC [MindMed Announces New Employee Inducement Grant](https://www.quantisnow.com/insight/mindmed-announces-new-employee-inducement-grant-6315868)
- 2025-12-01 21:01 UTC [MindMed Announces New Employee Inducement Grants](https://www.quantisnow.com/insight/mindmed-announces-new-employee-inducement-grants-6297558)
- 2025-11-06 21:18 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Mind Medicine (MindMed) Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-mind-medicine-mindmed-inc-6265873)
- 2025-11-06 21:12 UTC [SEC Form 8-K] [Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-filed-sec-form-8-k-results-of-6265753)
- 2025-11-06 21:01 UTC [Public Offering] [MindMed Reports Q3 2025 Financial Results and Business Updates](https://www.quantisnow.com/insight/mindmed-reports-q3-2025-financial-results-and-business-updates-6265133)
- 2025-11-05 12:01 UTC [Conference Announcement] [MindMed to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/mindmed-to-participate-in-upcoming-investor-conferences-6260844)
- 2025-11-03 21:01 UTC [MindMed Announces New Employee Inducement Grant](https://www.quantisnow.com/insight/mindmed-announces-new-employee-inducement-grant-6256315)
- 2025-11-03 12:01 UTC [Public Offering] [Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-announces-closing-of-approximately-259-million-6255372)
- 2025-10-31 13:22 UTC [SEC Form 8-K] [Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-filed-sec-form-8-k-entry-into-6253967)
- 2025-10-31 00:38 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Mind Medicine (MindMed) Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-mind-medicine-mindmed-inc-6253501)
- 2025-10-30 20:01 UTC [Conference Announcement] [MindMed to Report Q3 2025 Financial Results on November 6, 2025](https://www.quantisnow.com/insight/mindmed-to-report-q3-2025-financial-results-on-november-6-6252313)
- 2025-10-30 02:14 UTC [Public Offering] [Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-announces-pricing-of-225-million-public-6250664)
- 2025-10-29 20:11 UTC [SEC Form 8-K] [Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-filed-sec-form-8-k-results-of-6249993)
- 2025-10-29 20:05 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Mind Medicine (MindMed) Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-mind-medicine-mindmed-inc-6249884)
- 2025-10-29 20:01 UTC [Public Offering] [Mind Medicine (MindMed) Inc. Announces Proposed Public Offering](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-announces-proposed-public-offering-6249725)
- 2025-10-14 20:01 UTC [MindMed Announces New Employee Inducement Grant](https://www.quantisnow.com/insight/mindmed-announces-new-employee-inducement-grant-6232244)
- 2025-10-13 12:54 UTC [Analyst Coverage Initiated] [Needham initiated coverage on MindMed with a new price target](https://www.quantisnow.com/insight/needham-initiated-coverage-on-mindmed-with-a-new-price-target-6230727)
- 2025-09-26 21:35 UTC [SEC Form 4] [Chief Legal Officer Sullivan Mark sold $110,186 worth of shares (11,278 units at $9.77), decreasing direct ownership by 4% to 293,852 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-legal-officer-sullivan-mark-sold-110186-worth-of-shares-6213435)
- 2025-09-26 21:35 UTC [SEC Form 4] [Chief Executive Officer Barrow Robert sold $252,037 worth of shares (25,797 units at $9.77), decreasing direct ownership by 3% to 804,268 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-barrow-robert-sold-252037-worth-of-shares-6213434)
- 2025-09-26 21:34 UTC [SEC Form 4] [Chief Medical Officer Karlin Daniel sold $75,268 worth of shares (7,704 units at $9.77), decreasing direct ownership by 2% to 430,625 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-karlin-daniel-sold-75268-worth-of-shares-6213431)
- 2025-09-25 20:43 UTC [SEC Form 144] [SEC Form 144 filed by Mind Medicine (MindMed) Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mind-medicine-mindmed-inc-6212127)
- 2025-09-22 20:01 UTC [MindMed Announces New Employee Inducement Grants](https://www.quantisnow.com/insight/mindmed-announces-new-employee-inducement-grants-6208002)
- 2025-09-19 11:00 UTC [New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)](https://www.quantisnow.com/insight/new-mindmed-retrospective-study-presented-at-psych-congress-2025-reveals-6206265)
- 2025-09-08 20:01 UTC [MindMed Announces New Employee Inducement Grants](https://www.quantisnow.com/insight/mindmed-announces-new-employee-inducement-grants-6193171)
- 2025-09-04 15:15 UTC [SEC Form 8-K] [Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-filed-sec-form-8-k-other-events-6189716)
- 2025-09-04 15:05 UTC [Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)](https://www.quantisnow.com/insight/journal-of-the-american-medical-association-jama-publishes-results-from-6189707)
- 2025-08-28 11:00 UTC [Conference Announcement] [MindMed to Participate in September Investor Conferences](https://www.quantisnow.com/insight/mindmed-to-participate-in-september-investor-conferences-6181651)
- 2025-08-11 20:01 UTC [MindMed Announces New Employee Inducement Grants](https://www.quantisnow.com/insight/mindmed-announces-new-employee-inducement-grants-6158129)
- 2025-08-04 12:21 UTC [Analyst Coverage Resumed] [Oppenheimer resumed coverage on MindMed with a new price target](https://www.quantisnow.com/insight/oppenheimer-resumed-coverage-on-mindmed-with-a-new-price-target-6144064)
- 2025-07-31 20:20 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Mind Medicine (MindMed) Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-mind-medicine-mindmed-inc-6141270)
- 2025-07-31 20:10 UTC [SEC Form 8-K] [Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mind-medicine-mindmed-inc-filed-sec-form-8-k-results-of-6141082)
- 2025-07-31 20:01 UTC [Earnings Date] [MindMed Reports Q2 2025 Financial Results and Business Updates](https://www.quantisnow.com/insight/mindmed-reports-q2-2025-financial-results-and-business-updates-6140789)
- 2025-07-24 11:00 UTC [Earnings Date] [MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025](https://www.quantisnow.com/insight/mindmed-to-report-second-quarter-2025-financial-results-on-july-6130659)
- 2025-07-14 20:01 UTC [MindMed Announces New Employee Inducement Grants](https://www.quantisnow.com/insight/mindmed-announces-new-employee-inducement-grants-6119139)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MNMD
- Earnings history: https://www.quantisnow.com/earnings/MNMD
- Dividend history: https://www.quantisnow.com/dividends/MNMD
- Insider transactions: https://www.quantisnow.com/insiders/MNMD
- Options chain: https://www.quantisnow.com/options/MNMD
- SEC 8-K filings only: https://www.quantisnow.com/company/MNMD/8-k
- RSS and alerts for MNMD: https://www.quantisnow.com/docs/rss-feeds.md